India to Malaysia: Oxaliplatin Export Trade Route
India has recorded 23 verified shipments of Oxaliplatin exported to Malaysia, representing a combined trade value of $869.7K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $37.8K USD. The leading Indian exporter is FRESENIUS KABI ONCOLOGY LIMITED, which accounts for 84% of total export value with 19 shipments worth $728.8K USD. On the buying side, FRESENIUS KABI MALAYSIA SDN BHD is the largest importer in Malaysia with $663.2K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Malaysia Oxaliplatin corridor is one of India's established pharmaceutical export routes, with 23 shipments documented worth a combined $869.7K USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 84% of all export value, reflecting the consolidated nature of India's oxaliplatin manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $37.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with oxaliplatin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 30.3%, placing it at rank #10 among India's top oxaliplatin export destinations globally.
On the import side, key buyers of Indian oxaliplatin in Malaysia include FRESENIUS KABI MALAYSIA SDN BHD, FRESENIUS KABI MALAYSIA SDN.BHD. , FRESENIUS KABI MALAYSIA SDN BHD. and 2 others. FRESENIUS KABI MALAYSIA SDN BHD is the single largest importer with 17 shipments valued at $663.2K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ3
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#10
- Annual growth+30.3%
- Demand growth+27.2%
- Regulatory ease89/100
Top 10 Indian Oxaliplatin Exporters to Malaysia
Showing top 10 of 2 Indian suppliers exporting Oxaliplatin to Malaysia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED Avg $38.4K per shipment | 19 | $728.8K | 83.8% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED Avg $35.2K per shipment | 4 | $140.8K | 16.2% |
This table shows the top 10 of 2 Indian companies exporting oxaliplatin to Malaysia, ranked by total trade value. The listed exporters are: FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED . FRESENIUS KABI ONCOLOGY LIMITED is the dominant supplier with 19 shipments worth $728.8K USD, giving it a 84% market share.
Top 10 Oxaliplatin Importers in Malaysia
Showing top 10 of 5 known buyers in Malaysia receiving Oxaliplatin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian oxaliplatin in Malaysia include FRESENIUS KABI MALAYSIA SDN BHD, FRESENIUS KABI MALAYSIA SDN.BHD. , FRESENIUS KABI MALAYSIA SDN BHD., FRESENIUS KABI MALAYSIA SDN BHD , FRESENIUS KABI MALAYSIA SDN.BHD . The largest importer is FRESENIUS KABI MALAYSIA SDN BHD, accounting for $663.2K USD across 17 shipments — representing 76% of all oxaliplatin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI MALAYSIA SDN BHD | 17 | $663.2K | 76.3% |
| 2 | FRESENIUS KABI MALAYSIA SDN.BHD. | 1 | $86.7K | 10.0% |
| 3 | FRESENIUS KABI MALAYSIA SDN BHD. | 2 | $65.6K | 7.5% |
| 4 | FRESENIUS KABI MALAYSIA SDN BHD | 2 | $33.3K | 3.8% |
| 5 | FRESENIUS KABI MALAYSIA SDN.BHD | 1 | $20.9K | 2.4% |
Top 10 Oxaliplatin Formulations Imported by Malaysia
Showing top 10 of 19 product formulations shipped on the India to Malaysia Oxaliplatin route, ranked by trade value
Malaysia imports a wide range of oxaliplatin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — OXITAN OXALIPLATIN INJ. 50MG/10ML VIALB/N: 87230416AB 87230416AC MD:09/23 ED:08/25 — accounts for $276.4K USD across 3 shipments. There are 19 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | OXITAN OXALIPLATIN INJ. 50MG/10ML VIALB/N: 87230416AB 87230416AC MD:09/23 ED:08/25 | 3 | $276.4K | 31.8% |
| 2 | OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL | 3 | $120.0K | 13.8% |
| 3 | OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL, BATCH NO. 87250025AC, MFG. DT. 02/2025, EXP. DT. 01/2027 | 1 | $88.5K | 10.2% |
| 4 | OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL, BATCH NO. 87240099AA, MFG. DT. 02/2024, EXP. DT. 01/2026 | 1 | $56.0K | 6.4% |
| 5 | OXITANOXALIPLATININJ.100MG/20ML VIALB NO-87230396BA MANUFACTURING .DT. 08/2023 EXP.DT. 07/2025 | 1 | $54.7K | 6.3% |
| 6 | OXITAN(OXALIPLATIN)INJ.50MG/10ML VIALB NO-87240151AAMFG.04/2024 EXP.DT. 03/2026 | 1 | $45.3K | 5.2% |
| 7 | OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL(BATCH NO. 87250056AA, MFG. DT. 02/2025, EXP. DT. 01/2027) | 1 | $33.2K | 3.8% |
| 8 | OXITAN OXALIPLATIN INJ 100MG 20ML VIAL B N 87230093AA 87230094AB MD 02 23 ED 01 25 | 1 | $30.8K | 3.5% |
| 9 | OXITAN (OXALIPLATIN) USP INJ. 100MG/20MLVIAL (BATCH NO. 87250065AA, MFG. DT. 03/2025, EXP. DT. 02/2027) | 1 | $30.2K | 3.5% |
| 10 | OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL, BATCH NO. 87240099AK, MFG. DT. 02/2024, EXP. DT. 01/2026 | 1 | $21.1K | 2.4% |
Showing top 10 of 19 Oxaliplatin formulations imported by Malaysia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 14 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's oxaliplatin exports to Malaysia are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Malaysia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 100% of total trade value on this route. The average shipment value of $37.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as oxitan (oxaliplatin) inj. 50mg/10ml vial and oxitan (oxaliplatin) inj. 50mg/10ml vial, batch no. 87250025ac, mfg. dt. 02/2025, exp. dt. 01/2027, suggesting that buyers in Malaysia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FRESENIUS KABI MALAYSIA SDN BHD is the largest importer with 17 shipments worth $663.2K USD — representing 76% of all oxaliplatin imports from India on this route.
Route Statistics
- Trade Volume
- $869.7K
- Avg. Shipment
- $37.8K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~18 days
- Annual Growth
- +30.3%
Related Analysis
Other Oxaliplatin Routes
Unlock the Full India to Malaysia Oxaliplatin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 23 shipments on this route.
Frequently Asked Questions — India to Malaysia Oxaliplatin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Oxaliplatin to Malaysia?
The leading Indian exporters of Oxaliplatin to Malaysia are FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED . FRESENIUS KABI ONCOLOGY LIMITED holds the largest market share at approximately 84% of total trade value on this route.
Q What is the total value of Oxaliplatin exports from India to Malaysia?
India exports Oxaliplatin to Malaysia worth approximately $869.7K USD across 23 recorded shipments. The average value per shipment is $37.8K USD.
Q Which ports does India use to ship Oxaliplatin to Malaysia?
The most active port of origin is DELHI AIR with 14 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Malaysia for Oxaliplatin?
The average transit time for Oxaliplatin shipments from India to Malaysia is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Malaysia Oxaliplatin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.3% with demand growth tracking at 27.2%. The route is ranked #10 among India's top Oxaliplatin export destinations globally.
Q How many suppliers are active on the India to Malaysia Oxaliplatin route?
There are currently 2 active Indian suppliers exporting Oxaliplatin to Malaysia. The market is moderately concentrated with FRESENIUS KABI ONCOLOGY LIMITED accounting for 84% of total shipment value.
Q Who are the main importers of Oxaliplatin from India in Malaysia?
The leading importers of Indian Oxaliplatin in Malaysia include FRESENIUS KABI MALAYSIA SDN BHD, FRESENIUS KABI MALAYSIA SDN.BHD. , FRESENIUS KABI MALAYSIA SDN BHD., FRESENIUS KABI MALAYSIA SDN BHD , FRESENIUS KABI MALAYSIA SDN.BHD . FRESENIUS KABI MALAYSIA SDN BHD is the largest buyer with 17 shipments worth $663.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Malaysia export trade corridor identified from Indian Customs (DGFT) records for Oxaliplatin.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in Malaysia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 23 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
23 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists